ClinicalTrials.gov
public full text
Public Domain
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
This pilot phase 0 trial studies how well enzalutamide works before surgery in treating patients with kidney cancer. Androgens are a type of hormone produced by the body that may cause kidney tumors to grow. Anti-hormone therapy, such as enzalutamide, may lessen the amount of androgens produced by the body and keep kidney tumors from growing.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers#1126459
- Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery#1096382
- Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia#992957
- Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer#885466
- A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)#878893
Record · ID 807045
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive